about
Biophytum sensitivum: Ancient medicine, modern targetsMultimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models.A review on various targeted anticancer therapies.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Impact of proteomics on bladder cancer research.An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.Imaging of angiogenesis: from morphology to molecules and from bench to bedside.Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.Nanoparticles as new tools for inhibition of cancer angiogenesis.CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.EMT and Treatment Resistance in Pancreatic Cancer.
P2860
Q24630506-E849B2ED-34EC-4229-AA57-0962417AADB0Q33572940-16F930C0-A45F-4A3A-9F2B-80358DB1A680Q33985961-819C1A7A-FD76-45DD-B5E2-50A4ABC1D082Q34164735-6E9A8C96-C0DC-42CA-AB99-42948DF3E76CQ34273411-9A8870EE-B6E2-48A6-A517-631ADB91A4E2Q35785226-5DADB7C6-3D77-4915-9206-841AD8FC66A7Q35955457-D8677B38-C73C-4D09-BE40-FEE5F0BC9FFAQ36005858-5BB0092F-0526-4BA7-853A-3F4FB241B1DDQ36131307-AABEBE33-414C-48C6-BA75-EA9039E4F236Q36611325-3900FF4A-BCA4-4C70-980D-92DDFF826165Q36742945-2900E934-B2FE-41C1-A4AC-CC084E39E35AQ37071525-AF77BB6A-5A98-4777-9A64-B2C09D594532Q37501825-22B71F5C-9025-423E-89A8-39FEA7BCB4AEQ37601970-577179EF-8F01-49D6-B879-7017C0A1AC3BQ38103859-F931CA9A-C5B3-44D2-A789-0A68FBE84F7EQ39329359-A8903077-17AE-4DA5-919B-7BB3CED40F00Q41629417-6FAE5374-A971-49D0-B7BA-452A1A624F17Q41670877-2370B9A7-4E02-4FF3-A57A-4E0AC6D1A6F5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiogenesis: a target for cancer therapy.
@ast
Angiogenesis: a target for cancer therapy.
@en
type
label
Angiogenesis: a target for cancer therapy.
@ast
Angiogenesis: a target for cancer therapy.
@en
prefLabel
Angiogenesis: a target for cancer therapy.
@ast
Angiogenesis: a target for cancer therapy.
@en
P356
P1476
Angiogenesis: a target for cancer therapy.
@en
P2093
Davide Melisi
Giampaolo Tortora
P356
10.2174/1381612043453595
P577
2004-01-01T00:00:00Z